Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

An Observational Study of Xeloda (Capecitabine) and Oxaliplatin Prior and Concurrent To Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer
An Observational Study of Xeloda (Capecitabine) and Oxaliplatin Prior and Concurrent To Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer

NCT01339832

CompletedN/A

Sponsor: Hoffmann-La Roche

Conditions: Colorectal Cancer

Countries: Switzerland

This observational study is a follow-up study of protocol ML18280. Survival data of patients who took part in and concluded study ML18280 will be collected for up to 5 years after LPLV of ML18270.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Patients who took part in and concluded study ML18280 according to protocol

Exclusion Criteria:

* N/A
Locations (5)
  • Basel, Switzerland
  • Chur, Switzerland
  • Lucerne, Switzerland
  • Sankt Gallen, Switzerland
  • Zurich, Switzerland